Sayed Hamid Mousavi1, Shafi Ullah Zahid2, Kalimullah Wardak3, Kazim Ali Azimi4, Sayed Mohammad Reza Hosseini5, Marzia Wafaee6, Kuldeep Dhama7, Ranjit Sah8, Ali A Rabaan9, Kovy Arteaga-Livias10, D Katterine Bonilla-Aldana11, Alfonso J Rodriguez-Morales12. 1. Department of Clinical Biochemistry, Faculty of Medical Sciences, Kateb University, Kabul, Afghanistan; Afghanistan National Charity Organization for Special Diseases, Kabul, Afghanistan. 2. Department of Neurosurgery, Jamhuriat Hospital, Kabul, Afghanistan. 3. Department of Orthopedics and Traumatology, Wazir Akbar Khan Hospital, Kabul, Afghanistan. 4. Medical Research Center, Razi Institute of Higher Education, Kabul, Afghanistan; Central Public Health Laboratory, Kabul, Afghanistan. 5. Department of Public Health, Faculty of Medical Sciences, Ghalib University, Kabul, Afghanistan. 6. Faculty of Chemistry, Kabul University, Kabul, Afghanistan. 7. Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India. 8. Department of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal. 9. Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia. 10. Universidad Científica del Sur, Lima, Peru; Facultad de Medicina, Universidad Nacional Hermilio Valdizán, Huánuco, Peru. 11. Semillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las Américas, Sede Pereira, Pereira, Risaralda, Colombia; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia. 12. Universidad Científica del Sur, Lima, Peru; Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia; Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Americas Pereira, Risaralda, Colombia. Electronic address: arodriguezm@utp.edu.co.
To the editor,We read with great interest the article by Pradhan et al., about the current interventions for the Coronavirus Disease 2019 (COVID-19) prevention (1), discussing different strategies to be applied at individuals for avoiding the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. We would like to compliment and discuss the importance of prevention and public health of the use of geographical information systems (GIS)-based mapping, recently applied in other few countries (2,3), now in this analysis, for Afghanistan. Even more, Afghanistan is a country where few studies have been so far published (4, 5, 6). For these reasons, we have developed epidemiological maps of the incidence rates using official populations, by provinces, as well for case fatality rates (CFR%), mortality rates, and the proportion of patients recovered, from COVID-19 in Afghanistan using GIS.Surveillance cases, deaths and recovery data of the cumulative number of April 26 and May 3, 2020, officially reported by the Afghanistan health authorities were used to estimate the cumulated incidence rates, mortality rates, CFR% and recovery rate (%) on those dates using reference population data on SARS-CoV-2 RT-PCR confirmed infections (cases/100,000 pop) and to develop the maps by provinces, using the GIS software Kosmo® 3.1. Starting on February 24, 2020, the first cases of SARS-CoV-2 was confirmed in a 35 year old man (3). He was part of a group of three returning travelers at Herat, who had recently come from Qom, Iran, suspected of COVID-19infection (5). On March 22, 2020, the government took the lockdown measure for the city of Herat. Four days later extended the lockdown to Kabul, Kandahar, and Logar provinces.Up to April 26, 2020, after 62 d of epidemics, 1,463 cases of COVID-19 were reported in the country, for a cumulated rate of 4.76 cases/100,000 population, reaching 2,706 cases during May 3, 2020, for a rate of 8.81. All the provinces of the country have been affected except Nurestan (Nuristan), with rates ranging from 0.2 (Badakhshan) to 28.9 cases/100,000 population (Nemroz/Nimroz) (Figure 1
). At Herat (Hirat), where the first case was reported for May 3, 2020, 541 cases were confirmed with 25.8 an incidence rate of cases/100,000 population. The highest number of cases have been reported in Kabul, the capital, 755, with a rate of 15.0 cases/100,000 population (Figure 1). From April 26–May 3, in addition to Nimroz, two additional provinces reached an incidence higher than 25 cases/100,000 population, Hirat, and Kandahar (Figure 1). From the total number of cases up to May 3, 2020, 85 died (3.1%), but that CFR% ranged at provinces from 0–50% (Jowzjan and Paktika) in the two time-point measured (Figure 1), yielding a cumulative mortality rate of 0.28 deaths/100,000 population at the national level, ranging at provinces from 0–0.88 deaths/100,000 population (Balkh) (Figure 1). Finally, 345 cases have recovered (12.7%), also ranging in provinces from 0–55% for May 3, 2020 (Figure 1). Maps showed that while southwestern provinces have a higher incidence, the fatality and mortality rates seem higher in northeastern provinces (Figure 1).
Figure 1
Key points related to the current technological advances on emerging approaches to improve control and particularly diagnosis of the SARS-CoV-2/COVID-19 pandemic.
Key points related to the current technological advances on emerging approaches to improve control and particularly diagnosis of the SARS-CoV-2/COVID-19 pandemic.Afghanistan cases originated from a neighbor country, Iran, which currently is in the top ten of countries globally regarding COVID-19 cases (207,525) (June 22, 2020) (5). At the same time, that contrast highly with another border country, Turkmenistan, which has no reported cases yet (Figure 1). But the government has worked to control information about the virus, and experts suspect that it may be spreading in the country unreported.Given the current findings, population-based interventions should be targeted, especially in those high-risk areas for occurrence and fatalities. In Afghanistan, health care delivery is already a major cross-cutting challenge. Although efforts to rebuild the health care systems in Afghanistan have been made, both acute and chronic illnesses remain as significant medical and critical governance gaps to be remedied. Besides, health care facilities and medical equipment are not adequate in the country. There is a need for medical and scientific expertise to clinically and sociologically contextualize and interpret diagnostic tests as well as drugs and vaccines that will be deployed in the coming months as part of the planetary collective response to the COVID-19 pandemic (6).Besides, specific studies in vulnerable populations such as those displaced by conflicts and people affected by natural disasters should be performed. Afghanistan is still endemic for many emerging infectious diseases such as poliomyelitis and measles (7). Because of inadequate health-care services in Afghanistan, many ill people will try to seek medical care overseas. At the same time, broad travel restrictions and flight suspensions come into force in the country.
Authors: Carlos Franco-Paredes; Jose I Santos-Preciado; Andres F Henao-Martinez; Alfonso J Rodriguez-Morales; Peter Carrasco Journal: Lancet Infect Dis Date: 2020-01 Impact factor: 25.071
Authors: Sayed H Mousavi; Jaffer Shah; Hoang T N Giang; Tareq M A Al-Ahdal; Shafi U Zahid; Fardina Temory; Feda M Paikan; Sedighe Karimzadeh; Nguyen T Huy Journal: Lancet Infect Dis Date: 2020-03-23 Impact factor: 25.071